Gingival overgrowth during orthodontic treatment Oral Health
Conditions
Interventions
The sample was divided into two groups: the first group was treated using a CO2 laser, and the second group using a 450nm Diode laser. The following variables were studied: gingival overgrowth, period
Sponsors
Damascus University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients treated with fixed orthodontics 2. Patients with gingival overgrowth
Exclusion criteria
Exclusion criteria: 1. Pregnant and breastfeeding women. 2. Smokers. 3. Patients taking medications that cause gingival enlargement, such as (calcium channel blockers, anticonvulsants, immunosuppressants), and patients taking blood thinners or bisphosphonate medications. 3. Patients with diabetes. 4. Patients with infectious diseases such as (hepatitis, acquired immunodeficiency virus). 5. Endocrine disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The clinical crown length, gingival overgrowth index, and periodontal pocket depth will be measured over the following periods: before intervention, after 15 days, 1 month, 3 months, and 6 months. 2. The pain index will be measured over the following periods: day of treatment, after 1 day, 2 days, 3 days, and after 1 week. 3. The bleeding index will be measured during the surgical procedure and after the procedure. 4. Operation time will be measured separately for each group. 5. The clinical healing index will be measured over the following periods: after 1 week and after 1 month. 6. The scar will be evaluated over the following periods: after surgery, after 1 month, 3 months, and 6 months. 7. The recurrence index will be measured over the following periods: after 1 month, 3 months, and 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Syria
Contacts
Public ContactRose Assaf
Outcome results
None listed